Eden Research (LON:EDEN – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported GBX (0.36) EPS for the quarter, Digital Look Earnings reports. Eden Research had a negative net margin of 44.31% and a negative return on equity of 15.05%.
Eden Research Stock Performance
EDEN stock opened at GBX 2.17 on Thursday. The stock’s 50 day simple moving average is GBX 2.72 and its 200 day simple moving average is GBX 3.16. The company has a current ratio of 2.25, a quick ratio of 2.42 and a debt-to-equity ratio of 1.43. Eden Research has a 12-month low of GBX 1.96 and a 12-month high of GBX 5. The stock has a market capitalization of £17.43 million, a PE ratio of -4.90 and a beta of 1.57.
About Eden Research
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.
Featured Articles
- Five stocks we like better than Eden Research
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
